Philip Morris International Inc. vs Quantumscape Corp — how do they compare? Philip Morris International Inc. trades at $195 (market cap $293.07B), while Quantumscape Corp trades at $5.65 (market cap $3.72B). The key difference: Philip Morris International Inc. is far larger — about 78.8× Quantumscape Corp's market cap, and Philip Morris International Inc. pays a 3.13% dividend while Quantumscape Corp pays none. Which is the better fit depends on your goals.
| PM | QS | |
|---|---|---|
Market Cap | $293.07B | $3.72B |
Sector | Consumer Staples | Consumer Cyclical |
52-Week High | $192.98 | $18.44 |
52-Week Low | $144.33 | $5.86 |
Enterprise Value | $339.57B | $2.89B |
Dividend Yield | 3.13% | — |
Signals from Pluang's Aura AI — not financial advice
Philip Morris International (PM) trades at $194.30, up 0.82% today, with strong analyst support (68% buy ratings) and a consensus price target of $194. The stock shows bullish technical momentum above key support levels, supported by robust fundamentals including 2025 revenue of $40.65B and net income of $11.35B. Recent news highlights include a $500M impairment charge and updated 2026 guidance, while the IQOS brand gained recognition as a top global brand.
PM offers stable dividend income and growth potential, but faces headwinds from cost pressures, currency volatility, and regulatory risks in tobacco markets. The current valuation at 26.47 P/E appears reasonable given earnings consistency, though investors should monitor margin trends and illicit market impacts in Europe. Near-term price action hinges on Q2 2026 earnings versus the $2.04 EPS estimate.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →